UA Researchers Study Increasing Lifespan and Immune FunctionContinue reading
Author Archive: AZBio
Tech Launch Arizona Breaking Records For Commercialization
A Record Year for Technology Commercialization at the UA. In the last fiscal year, the UA executed 39 exclusive licenses and 72 total licenses, among other successes.Continue reading
FDA Approves the SynCardia Total Artificial Heart With SynHall Valves
SynCardia Systems, Inc., now controls last key component in heart manufacturing.Continue reading
AZBio CEO Joan Koerber-Walker shares insights on innovation and workforce education
In an interview at BIO 2014, AZBio’s President and CEO introduces AZBio and looks at how time, treasury, and talent are key to growing a life science industry.Continue reading
Arizona State University scientist Roy Curtiss garners AZBio’s Pioneer Award for Lifetime Achievement
Roy Curtiss, III, Ph.D., of the Biodesign Institute at Arizona State University, has been selected as the recipient of the 2014 AZBio Pioneer Award for Lifetime Achievement by the Arizona Bioindustry Association.Continue reading
Arizona Bioscience Week Celebrates Success and Creates Oportunity
Arizona will celebrate Arizona Bioscience Week September 15th – 19th, 2014. AZBio will celebrate outstanding achievements of the industry’s leaders and companies at the AZBio Awards on September 17th and connect life science investors with exciting companies from across the Rocky Mountain Southwest Region at the White Hat Life Science Investor Conference on September 18, 2014. Continue reading
VWR-BIO Laboratory Products & Services Business Solutions Program Expands Product Brand Access
In addition to the product brands currently offered, VWR, BIO, and Thermo Scientific are excited to announce expanded access to over 15 additional product brands through the VWR/BIO Business Solutions Program.Continue reading
NuvOx announces Phase Ib trial for Glioblastoma and additional NIH funding
NuvOx Pharma, a privately held biotechnology company based in Tucson, Arizona, announced that on July 14th, it began a Phase Ib clinical trial of its new drug NVX-108 in patients with glioblastoma, a deadly form of brain cancer.Continue reading
AdvaMed and MEDEC Approve Guidances on Ethical Relationships with Third-Party Distributors
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) and the Canadian medical technology association MEDEC announce that MEDEC recently approved a number of guidances and tools designed to promote ethical interactions between medical device and diagnostics companies and third-party distributors.
Merz Finalizes Acquisition of Medical Device Company Ulthera, Inc.
Company’s Largest Acquisition Strengthens Aesthetics BusinessContinue reading